An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for SEAGEN Inc
| Ticker | SGEN |
| FIGI | BBG000BH0FR6 |
| CUSIP | 81181C104 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 0 / 0.0% |
| Number of Shares | 0 |
About
Seagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Wikipedia